Skip Navigation


European Heart Journal Advance Access originally published online on November 30, 2004
European Heart Journal 2005 26(4):332-342; doi:10.1093/eurheartj/ehi052
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/4/332    most recent
ehi052v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yarnell, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yarnell, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2004. All rights reserved. For Permissions, please e-mail: journals.permissions{at}oupjournals.org

Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study{dagger}

John Yarnell1,*, Evelyn McCrum1, Ann Rumley2, Christopher Patterson1, Veikko Salomaa3, Gordon Lowe2, Alun Evans1 on behalf of the MONICA Optional Haemostasis Study Investigators

1Department of Epidemiology and Public Health, Queen's University of Belfast, UK
2Department of Medicine, University of Glasgow, UK
3Department of Epidemiology, KTL-NPHI, Helsinki, Finland

Received 18 May 2004; revised 18 October 2004; accepted 21 October 2004; online publish-ahead-of-print 30 November 2004.

* Corresponding author. Tel: +44 28 90632746; fax: +44 28 90231907. E-mail address: j.yarnell{at}qub.ac.uk

See page 317 for the editorial comment on this article (doi:10.1093/eurheartj/ehi087)

Aims Classical risk factors do not fully explain international differences in risk of coronary heart disease (CHD). We therefore measured thrombotic and inflammatory markers in a substudy of the WHO MONICA project and correlated these with CHD event rates.

Methods and results We measured levels of fibrinogen (clottable and nephelometric), von Willebrand factor (vWf), tissue plasminogen activator antigen, plasminogen activator inhibitor activity, fibrin D-dimer, plasma viscosity, C-reactive protein, and total cholesterol in 12 MONICA populations (listed at the end of this paper), all but one European. Men and women aged 45–64 years were studied from 10 countries. All samples were collected using a carefully standardized protocol, and analysed centrally. Results were available for 3996 subjects (nephelometric fibrinogen and viscosity), 2378 subjects (other thrombotic assays), and 1757 subjects (C-reactive protein and total cholesterol). Significant differences in levels of thrombotic and inflammatory factors exist in MONICA populations mainly from European countries. These differences persist after adjustment for age, smoking habit, and body mass index. Cross-sectional correlations between coronary event rates and these thrombotic/inflammatory markers were significant for vWF antigen in both sexes, nephelometric fibrinogen in men, and D-dimer in women.

Conclusion In particular, vWF, nephelometric fibrinogen, and D-dimer should be examined in further research as potential risk factors which may help explain differences in coronary risk between European populations.

Key Words: Thrombosis • Risk markers • CHD • MONICA • Population studies


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Atherosclerosis, thrombosis, and inflammatory risk factors, from history and the laboratory to real life
John H. Zarifis
EHJ 2005 26: 317-318. [Extract] [Full Text]  



This article has been cited by other articles:


Home page
Am J EpidemiolHome page
Associations of Plasma Fibrinogen Levels with Established Cardiovascular Disease Risk Factors, Inflammatory Markers, and Other Characteristics: Individual Participant Meta-Analysis of 154,211 Adults in 31 Prospective Studies: The Fibrinogen Studies Collaboration
Am. J. Epidemiol., October 15, 2007; 166(8): 867 - 879.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. R. Rudnicka, A. Rumley, G. D.O. Lowe, and D. P. Strachan
Diurnal, Seasonal, and Blood-Processing Patterns in Levels of Circulating Fibrinogen, Fibrin D-Dimer, C-Reactive Protein, Tissue Plasminogen Activator, and von Willebrand Factor in a 45-Year-Old Population
Circulation, February 27, 2007; 115(8): 996 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. H. Zarifis
Atherosclerosis, thrombosis, and inflammatory risk factors, from history and the laboratory to real life
Eur. Heart J., February 2, 2005; 26(4): 317 - 318.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.